- Consumer Products
- Latest 33.64
- Currency US$
- Change -0.23
- Percent Change -0.679 %
- Volume 2,684,416
- Mon Mar 10, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Mar 6||$-0.66||Apr 23||$-0.62|
12 months ended Mar 10, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.